Health Condition 1: E78- Disorders of lipoprotein metabolism and other lipidemias
Conditions
Interventions
Intervention1: Individualized homeopathic medicines plus concomitant care: Using centesimal potencies (CH) of approved homoeopathic medications is the intended intervention. The quantity and frequenc
Sponsors
D. N. De Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient suffering from newly diagnosed cases of dyslipidaemia with LDL-C levels of 100-189mg/dl 2. Framingham risk score less than 20% 3. Age between 18 and 65 years. 4. Participants of either sex or transgender.
Exclusion criteria
Exclusion criteria: 1. Patients not providing with written informed consent of participation. 2. Familial hypertriglyceridemia. 3. Person already taking lipid lowering agents. 4. History of myocardial infarction, stenting, coronary artery bypass surgery or stroke. 5. Pregnant, puerperal, and lactating women. 6. Non ambulatory patients 7. Undergoing homoeopathic treatment for any chronic disease within the last 6 months 8. Vulnerable population: Unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, diagnosed cases of unstable mental or psychiatric illness and self-reported immune-compromised state. 9. Uncontrolled hypertension, uncontrolled diabetes, nephritic syndrome, renal insufficiency, uncontrolled hypothyroidism, severe or active liver diseases or any other uncontrolled systemic diseases affecting the quality of life or organ failure. 10. Habits of tobacco chewing and/or smoking, alcoholism, and/or any other form(s) of substance abuse and/or dependence (TAPS tool) 11. Simultaneous participation in any other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood LDL cholesterol level (LDL-C)Timepoint: At baseline, and after 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| total cholesterol (TC),Triglycerides(TGs),HDL,VLDL,FBS,PPBS and liver enzymes (AST and ALT)Timepoint: At baseline, and after 3 months;Short form 12(SF-12) health survey questionnaireTimepoint: At baseline, monthly, up to 3 months | — |
Countries
India
Contacts
Public ContactVeena Prakash Bharti
D. N. De Homoeopathic Medical College and Hospital
Outcome results
None listed